| [1] |
Xu J, Qin X, Wang J，et al.Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer.J Cancer Res Clin Oncol，2011，137(9):1379-1396.
|
| [2] |
Jones R P, Vauthey J N, Adam R，et al.Effect of specialist decision-making on treatment strategies for colorectal liver metastases.Br J Surg，2012，99(9):1263-1269.
|
| [3] |
Schmoll H J, Van Cutsem E, Stein A，et al.ESMO Consensus Guidelines for management of patients with colon and rectal cancer.a personalized approach to clinical decision making.Ann Oncol，2012，23(10):2479-2516.
|
| [4] |
Power DG, Kemeny NE.Role of adjuvant therapy after resection of colorectal cancer liver metastases.J Clin Oncol，2010，28(13):2300-2309.
|
| [5] |
Nordlinger B, Sorbye H, Glimelius B，et al.Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer(EORTC IntergrouP trial 40983)：a randomised controlled trial.Lancet，2008，371(9617):1007-1016.
|
| [6] |
Primrose J, Falk S, Finch-Jones M，et al.Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis：the New EPOC randomised controlled trial.Lancet Oncol，2014，15(6):601-611.
|
| [7] |
Rong Z, Martel G, Vandenbroucke-Menu F，et al.Impact of peri-operative bevacizumab on survival in patients with resected colorectal liver metastases：an analysis of the LiverMetSurvey.HPB(Oxford)，2014，16(4):342-349.
|
| [8] |
Chua TC, Saxena A, Liauw W，et al.Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases.Ann Surg Oncol，2010，17(2):492-501.
|
| [9] |
Nordlinger B, Van Cutsem E, Gruenberger T，et al.Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases：recommendations from an expert panel.Ann Oncol，2009，20(6):985-992.
|
| [10] |
Adam R, Bhangui P, Poston G，et al.Is perioperative chemotherapy useful for solitary，metachronous，colorectal liver metastases？.Ann Surg，2010，252(5):774-787.
|
| [11] |
Bischof DA, Clary BM, Maithel SK，et al.Surgical management of disappearing colorectal liver metastases.Br J Surg，2013，100(11):1414-1420.
|
| [12] |
Petrelli F, Barni S．Resectability and outcome with anti-EGFR agents in patients with KRAS wild-type colorectal liver-limited metastases：a meta-analysis.Int J Colorectal Dis，2012，27(8):997-1004.
|
| [13] |
Van Cutsem E，FolPrecht G，Bokemeyer C，et al.Chemotherapy plus cetuximab as conversion therapy for patients with initially unresectable colorectal cancer liver metastases.Amsterdam，the Netherlands：2013.
|
| [14] |
Falcone A, Ricci S, Brunetti I，et al.Phase III trial of infusional fluorouracil，leucovorin，oxaliplatin，and irinotecan(FOLFOXIRI)compared with infusional fluorouracil，leucovorin，and irinotecan(FOLFIRI)as first-line treatment for metastatic colorectal cancer：the Gruppo Oncologico Nord Ovest.J Clin Oncol，2007，25(13):1670-1676.
|
| [15] |
Tappenden P, Jones R, Paisley S，et al.Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer.Health Technol Assess，2007，11(12):1-128.
|
| [16] |
Adam R, Haller DG, Poston G，et al.Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer-an expert review from the International Congress on Anti-Cancer Treatment(ICACT)2009.Ann Oncol，2010，21(8):1579-1584.
|
| [17] |
Poultsides GA, Servais EL, Saltz LB，et al.Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment.J Clin Oncol，2009，27(20):3379-3384.
|
| [18] |
Damjanov N, Weiss J, Haller DG.Resection of the primary colorectal cancer is not necessary in nonobstructed patients with metastatic disease.Oncologist，2009，14(10):963-969.
|
| [19] |
Aslam MI, Kelkar A, Sharpe D，et al.Ten years experience of managing the primary tumours in patients with stage IV colorectal cancers.Int J Surg，2010，8(4):305-313.
|
| [20] |
Stillwell AP, Buettner PG, Ho YH.Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone.World J Surg，2010，34(4):797-807.
|
| [21] |
Anwar S, Peter MB, Dent J，et al.Palliative excisional surgery for rimary colorectal cancer in atients with incurable metastatic disease.Is there a survival benefit? A systematic review.Colorectal Dis，2012，14(8):920-930.
|
| [22] |
Cirocchi R, Trastulli S, Boselli C，et al.Radiofrequency ablation in the treatment of liver metastases from colorectal cancer.Cochrane Database Syst Rev，2012，6:D6317.
|
| [23] |
Liang P, Wang Y, Yu X，et al.Malignant liver tumors：treatment with percutaneous microwave ablation-complications among cohort of 1136 patients.Radiology，2009，251(3):933-940.
|
| [24] |
Mocellin S, Pasquali S, Nitti D．Fluoropyrimidine-HAI(hepatic arterial infusion)versus systemic chemotherapy(SCT)for unresectable liver metastases from colorectal cancer.Cochrane Database Syst Rev，2009(3):D7823.
|
| [25] |
Ko YJ, Karanicolas PJ.Hepatic arterial infusion pump chemotherapy for colorectal liver metastases：an old technology in a new era.Curr Oncol，2014，21(1):e116-e121.
|
| [26] |
Xing M, Kooby DA, El-Rayes BF，et al.Locoregional therapies for metastatic colorectal carcinoma to the liver-An evidence-based review.J Surg Oncol，2014.doi： 10.1002/jso.23619. |